Filing Details

Accession Number:
0001127602-21-022226
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-19 16:39:54
Reporting Period:
2021-07-15
Accepted Time:
2021-07-19 16:39:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882796 Biocryst Pharmaceuticals Inc BCRX Biological Products, (No Disgnostic Substances) (2836) 621413174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1485939 B George Abercrombie Po Box 16069
Chapel Hill NC 27516
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-15 5,000 $2.63 8,000 No 4 M Direct
Common Stock Disposition 2021-07-15 5,000 $15.69 3,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option Disposition 2021-07-15 5,000 $0.00 5,000 $2.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2021-10-10 No 4 M Direct
Footnotes
  1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
  2. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.46 to $16.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
  3. The option vested 1/8 per month for a period of 8 months, beginning on October 10, 2011.